Genomics|Update|Non Communicable Diseases ► CANCER

Genomics|Update|Non Communicable Diseases

Volume 34  Number 2  January 15-22, 2015

Cancer

Economic evaluation of genetic screening for Lynch syndrome in Germany
Severin F, et al. Genet Med 2015 Jan

Emerging biomarkers in head and neck cancer in the era of genomics.
Hyunseok Kang, et al. Nature Reviews Clinical Oncology; 2015; 12:11-26

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
Pashayan N, et al. Genet Med 2015 Jan

Prostate cancer risk prediction based on complete prostate cancer family history.
Albright F et al., Prostate. 2014 Nov 18.

Screening for Lynch syndrome: It is time to shift the focus
Kidambi TD & Terdiman JP Dig Dis Sci 2015 Jan

Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. 
Gould-Suarez M, et al. Dig Dis Sci 2014 Dec;59(12)2913-26.

Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis
Ying M, et al. J Cancer Res Clin Oncol 2015 Jan

Validation of family cancer history data in high-risk families: The influence of cancer site, ethnicity, kinship degree, and multiple family reporters.
Tehranifar P, et al. Am J Epidemiol. 2015 Jan 7. pii: kwu258.